The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
12 February 2008
Employment effect (start)
1 January 2008
Foreseen end date
31 December 2009
Description
Novartis France, a subsidiary of the swiss pharmaceuticals group, has announced that it is to cut up to 100 jobs at different sites in France within the next two years. This restructuring is part of a larger plan which takes place at the international level aiming at cutting around 2,500 jobs. In doing so, the group hopes to save USD 1.6 billion by 2010. See related world factsheet.
Eurofound (2008), Novartis, Internal restructuring in France, factsheet number 66298, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66298.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
